- Integral to LeapFrog’s investment into Ascent Meditech
- 8 years’ experience in private equity, investment banking and corporate development
- Bachelor of Laws and Commerce (Hons) from the University of Western Australia
Jasvir PandherAssociate Director
Jasvir plays an integral role in LeapFrog’s Asia investment team, providing support across the full investment process and building value at LeapFrog’s portfolio companies. Jasvir was a key member of the team that made LeapFrog’s first investment into healthcare within Asia – $23 million in Ascent Meditech in India.
Prior to LeapFrog, Jasvir was an investment analyst at Davita Healthcare Partners in Singapore, where he originated, executed and managed Asia-Pacific healthcare investments.
Previously, he worked as an Analyst at Citigroup in Australia, where he advised on several M&A and capital-market transactions, including Veda Group’s $1.2 billion IPO and Qantas’s takeover defence. Jasvir holds a Bachelor’s Degree of Laws and Commerce from the University of Western Australia, where he graduated with honours.